-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.
-
Summary
-
OnKure Therapeutics, Inc. quarterly/annual Share-based Payment Arrangement, Expense history and growth rate from Q1 2020 to Q2 2025.
- OnKure Therapeutics, Inc. Share-based Payment Arrangement, Expense for the quarter ending June 30, 2025 was $2.91M, a 60.4% increase year-over-year.
- OnKure Therapeutics, Inc. Share-based Payment Arrangement, Expense for the twelve months ending June 30, 2025 was $8.26M.
- OnKure Therapeutics, Inc. annual Share-based Payment Arrangement, Expense for 2024 was $4.53M, a 2176% increase from 2023.
- OnKure Therapeutics, Inc. annual Share-based Payment Arrangement, Expense for 2023 was $199K, a 95.4% decline from 2022.
- OnKure Therapeutics, Inc. annual Share-based Payment Arrangement, Expense for 2022 was $4.32M, a 11% increase from 2021.
Share-based Payment Arrangement, Expense, Trailing 12 Months (USD)
Share-based Payment Arrangement, Expense, Quarterly (USD)
Share-based Payment Arrangement, Expense, YoY Quarterly Growth (%)